Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple checklist forecast PTSD after critical illness?

NCT ID NCT07747415

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time

Summary

This study asks whether routine medical data can predict which survivors of an emergency intensive care unit (EICU) stay will develop post-traumatic stress disorder (PTSD) one month after leaving the hospital. Researchers will follow about 800 adult patients, collecting details from their emergency department and ICU care—like vital signs, treatments, and severity of illness—and then assess them for PTSD using a standard diagnostic interview. The goal is to build a risk prediction model that helps doctors identify high-risk patients early and offer timely psychological support. No experimental treatments are involved; the study only observes and analyzes existing clinical information.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could give doctors a simple tool to spot EICU survivors at high risk of PTSD, enabling early psychological support and follow-up care.
What could go wrong
This is an observational study, not a treatment trial. The model may not be accurate enough for all patients, and PTSD risk depends on many personal factors not fully captured by clinical data.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients (≥18 years) admitted to the emergency department and subsequently transferred to the emergency intensive care unit (EICU) at Sir Run Run Shaw Hospital and other participating centers, who survive to EICU discharge and meet the study eligibility criteria.

Ages

18 years and older

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years * Admitted to the emergency department and subsequently transferred to the EICU at a participating center * Availability of emergency department-to-EICU clinical data suitable for model development * Proficient in the communication language, able to communicate normally, without cognitive impairment, dementia, or history of primary psychiatric disorders * Survive to EICU discharge * Glasgow Coma Scale (GCS) score ≥ 12 at EICU discharge or at follow-up * Willing to participate and able to provide informed consent (or consent obtained from a legally authorized representative or witness if the participant is unable to provide consent) Exclusion Criteria: * Voluntary withdrawal by the participant * Severe dementia, persistent coma, chronic vegetative state, or severe aphasia that precludes completion of PTSD assessment * Inability to establish any form of follow-up after discharge * Death prior to ICU discharge * Vulnerable populations other than elderly/critically ill patients (e.g., those with psychiatric disorders, cognitive impairment, pregnant women, illiterate individuals) * Other conditions deemed by the investigator to be unsuitable for participation or unable to ensure follow-up quality

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-traumatic stress disorder (PTSD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Sir Run Run Shaw Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, 310016, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.